News
Dexcom Study Shows CGM Benefits for Diabetes Patients Not Using Insulin
Dexcom CEO Jake Leach believes the findings could help establish CGM as a standard of care for type 2 diabetes patients who are not on insulin.
ADDRESS: Street, City, Country
PHONE: +(123) 456 789
E-MAIL: your-email@mail.com
Dexcom CEO Jake Leach believes the findings could help establish CGM as a standard of care for type 2 diabetes patients who are not on insulin.
HealthXplore is a digital platform dedicated to delivering insights into what’s new and what’s next in healthcare, pharmaceuticals, and medical innovation. We aim to bridge the gap between complex industry developments and informed audiences by presenting credible, timely, and engaging content.
Email Us: support@healthxploreindia.com
Contact: +91 8447496924
HealthXploreIndia @2026. All Rights Reserved.
